Unraveling the neuroprotective mechanisms of PrPC in excitotoxicity

Prion

Volumn 6, Issue 3, 2012, Pages 245-251

  Llorens, Franc ^a,b   Del Río, José Antonio ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Excitotoxicity; Glutamate receptors; Neuroprotection; Prion protein; Prionopathy; Synapse

Indexed keywords

BICUCULLINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; KAINIC ACID; LAMININ; MAGNESIUM; METABOTROPIC RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2D; NEUROTRANSMITTER RECEPTOR; PENTETRAZOLE; POSTSYNAPTIC DENSITY PROTEIN 95; PRION PROTEIN; SYNAPSIN I; SYNAPTOPHYSIN;

BRAIN ELECTROPHYSIOLOGY; CELL STRESS; COGNITIVE DEFECT; DEPRESSION; EPILEPSY; EPILEPTIC STATE; EXCITOTOXICITY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HIPPOCAMPUS; HISTOCHEMISTRY; KNOCKOUT MOUSE; KNOWLEDGE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; OPEN READING FRAME; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PURKINJE CELL; REVIEW; SEIZURE; SPERMATOGONIUM; SYNAPSE; SYNAPTIC TRANSMISSION;

ANIMALS; HUMANS; LONG-TERM POTENTIATION; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 10; NEURONS; PRIONS; PRPC PROTEINS; RECEPTORS, GLUTAMATE; SYNAPSES; SYNAPTIC TRANSMISSION;

MUS;

EID: 84863713439     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.19639     Document Type: Review

References (110)

1. Basler K, Oesch B, Scott M, Westaway D, Wälchli M, Groth DF, et al. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 1986; 46:417-28; PMID:2873895; http://dx.doi. org/10.1016/0092-8674(86)90662-8.
2. Gabriel JM, Oesch B, Kretzschmar H, Scott M, Prusiner SB. Molecular cloning of a candidate chicken prion protein. Proc Natl Acad Sci USA 1992; 89:9097-101; PMID:1409608; http://dx.doi. org/10.1073/pnas.89.19.9097.
3. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363-83; PMID:9811807; http://dx.doi. org/10.1073/pnas.95.23.13363.
4. Brown DR, Besinger A, Herms JW, Kretzschmar HA. Microglial expression of the prion protein. Neuroreport 1998; 9:1425-9; PMID:9631441; http://dx.doi.org/10.1097/00001756-199805110- 00032.
5. Moser M, Colello RJ, Pott U, Oesch B. Developmental expression of the prion protein gene in glial cells. Neuron 1995; 14:509-17; PMID:7695897; http:// dx.doi.org/10.1016/0896-6273(95)90307-0.
6. Ford MJ, Burton LJ, Morris RJ, Hall SM. Selective expression of prion protein in peripheral tissues of the adult mouse. Neuroscience 2002; 113:177-92; PMID:12123696; http://dx.doi.org/10.1016/S0306- 4522(02)00155-0.
7. Radovanovic I, Braun N, Giger OT, Mertz K, Miele G, Prinz M, et al. Truncated prion protein and Doppel are myelinotoxic in the absence of oligodendrocytic PrPC. J Neurosci 2005; 25:4879- 88; PMID:15888663; http://dx.doi.org/10.1523/ JNEUROSCI.0328-05.2005.
8. Liu T, Zwingman T, Li R, Pan T, Wong BS, Petersen RB, et al. Differential expression of cellular prion protein in mouse brain as detected with multiple anti-PrP monoclonal antibodies. Brain Res 2001; 896:118-29; PMID:11277980; http://dx.doi. org/10.1016/S0006-8993(01)02050-9.
9. Tichopad A, Pfaffl MW, Didier A. Tissue-specific expression pattern of bovine prion gene: quantification using real-time RT-PCR. Mol Cell Probes 2003; 17:5-10; PMID:12628587; http://dx.doi. org/10.1016/S0890-8508(02)00114-7.
10. Fujisawa M, Kanai Y, Nam SY, Maeda S, Nakamuta N, Kano K, et al. Expression of Prnp mRNA (prion protein gene) in mouse spermatogenic cells. J Reprod Dev 2004; 50:565-70; PMID:15514463; http:// dx.doi.org/10.1262/jrd.50. 565.
11. Zhang CC, Steele AD, Lindquist S, Lodish HF. Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal. Proc Natl Acad Sci USA 2006; 103:2184-9; PMID:16467153; http://dx.doi. org/10.1073/pnas.0510577103.
12. Kuwahara C, Takeuchi AM, Nishimura T, Haraguchi K, Kubosaki A, Matsumoto Y, et al. Prions prevent neuronal cell-line death. Nature 1999; 400:225-6; PMID:10421360; http://dx.doi.org/10.1038/22241.
13. Wong BS, Liu T, Li R, Pan T, Petersen RB, Smith MA, et al. Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J Neurochem 2001; 76:565-72; PMID:11208919; http://dx.doi.org/10. 1046/j.1471- 4159.2001.00028.x.
14. Büeler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992; 356:577-82; PMID:1373228; http://dx.doi.org/10.1038/ 356577a0.
15. Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, Hope J. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 1994; 8:121-7; PMID:7999308; http://dx.doi.org/10.1007/ BF02780662.
16. Bremer J, Baumann F, Tiberi C, Wessig C, Fischer H, Schwarz P, et al. Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci 2010; 13:310-8; PMID:20098419; http://dx.doi. org/10.1038/nn.2483.
17. Collinge J, Whittington MA, Sidle KC, Smith CJ, Palmer MS, Clarke AR, et al. Prion protein is necessary for normal synaptic function. Nature 1994; 370:295-7; PMID:8035877; http://dx.doi. org/10.1038/370295a0.
18. Rangel A, Madroñal N, Gruart A, Gavín R, Llorens F, Sumoy L, et al. Regulation of GABA(A) and glutamate receptor expression, synaptic facilitation and long-term potentiation in the hippocampus of prion mutant mice. PLoS One 2009; 4:7592; PMID:19855845; http://dx.doi.org/10.1371/journal. pone.0007592.
19. Maglio LE, Perez MF, Martins VR, Brentani RR, Ramirez OA. Hippocampal synaptic plasticity in mice devoid of cellular prion protein. Brain Res Mol Brain Res 2004; 131:58-64; PMID:15530652; http:// dx.doi.org/10.1016/j. molbrainres.2004.08.004.
20. Tobler I, Gaus SE, Deboer T, Achermann P, Fischer M, Rülicke T, et al. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 1996; 380:639-42; PMID:8602267; http:// dx.doi.org/10.1038/ 380639a0.
21. Heitz S, Grant NJ, Leschiera R, Haeberlé AM, Demais V, Bombarde G, et al. Autophagy and cell death of Purkinje cells overexpressing Doppel in Ngsk Prnp-deficient mice. Brain Pathol 2010; 20:119-32; PMID:19055638; http://dx.doi.org/10.1111/j.1750- 3639.2008.00245.x.
22. C) functions: the "ying and yang" of a relevant protein. Brain Res Rev 2009; 61:170-84; PMID:19523487; http://dx.doi. org/10.1016/j.brainresrev.2009.06.002.
23. Steele AD, Lindquist S, Aguzzi A. The prion protein knockout mouse: a phenotype under challenge. Prion 2007; 1:83-93; PMID:19164918; http://dx.doi. org/10.4161/pri.1.2.4346.
24. Pathmajeyan MS, Patel SA, Carroll JA, Seib T, Striebel JF, Bridges RJ, et al. Increased excitatory amino acid transport into murine prion protein knockout astrocytes cultured in vitro. Glia 2011; 59:1684-94; PMID:21766339; http://dx.doi. org/10.1002/glia.21215.
25. C) immunocytochemistry and expression of the green fluorescent protein reporter gene under control of the bovine PrP gene promoter in the mouse brain. J Comp Neurol 2004; 473:244- 69; PMID:15101092; http://dx.doi.org/10.1002/ cne.20117.
26. Fournier JG. Cellular prion protein electron microscopy: attempts/limits and clues to a synaptic trait. Implications in neurodegeneration process. Cell Tissue Res 2008; 332:1-11; PMID:18236081; http:// dx.doi.org/10.1007/s00441-007- 0565-5.
27. Ferrer I, Rivera R, Blanco R, Martí E. Expression of proteins linked to exocytosis and neurotransmission in patients with Creutzfeldt-Jakob disease. Neurobiol Dis 1999; 6:92-100; PMID:10343324; http://dx.doi.org/10.1006/ nbdi.1998.0226.
28. Kitamoto T, Shin RW, Doh-ura K, Tomokane N, Miyazono M, Muramoto T, et al. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am J Pathol 1992; 140:1285-94; PMID:1351366.
29. Zou WQ, Zhou X, Yuan J, Xiao X. Insoluble cellular prion protein and its association with prion and Alzheimer diseases. Prion 2011; 5:172- 8; PMID:21847014; http://dx.doi.org/10.4161/ pri.5.3.16894.
30. Simoneau S, Rezaei H, Salès N, Kaiser-Schulz G, Lefebvre-Roque M, Vidal C, et al. In vitro and in vivo neurotoxicity of prion protein oligomers. PLoS Pathog 2007; 3:125; PMID:17784787; http://dx.doi. org/10.1371/journal.ppat. 0030125.
31. Lloyd S, Mead S, Collinge J. Genetics of prion disease. Top Curr Chem 2011; 305:1-22; PMID:21528440; http://dx.doi.org/10.1007/128-2011-157.
32. Xiang W, Windl O, Westner IM, Neumann M, Zerr I, Lederer RM, et al. Cerebral gene expression profiles in sporadic Creutzfeldt-Jakob disease. Ann Neurol 2005; 58:242-57; PMID:16049922; http://dx.doi. org/10.1002/ana.20551.
33. Porto-Carreiro I, Février B, Paquet S, Vilette D, Raposo G. Prions and exosomes: from PrPC trafficking to PrPSc propagation. Blood Cells Mol Dis 2005; 35:143-8; PMID:16099696; http://dx.doi. org/10.1016/j.bcmd.2005.06.013.
34. Lewis V, Hooper NM. The role of lipid rafts in prion protein biology. Front Biosci 2011; 16:151-68; PMID:21196164; http://dx.doi.org/10.2741/3681.
35. Calella AM, Farinelli M, Nuvolone M, Mirante O, Moos R, Falsig J, et al. Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol Med 2010; 2:306-14; PMID:20665634; http:// dx.doi.org/10.1002/emmm.201000082.
36. Checler F, Vincent B. Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators. Trends Neurosci 2002; 25:616-20; PMID:12446128; http://dx.doi.org/10.1016/S0166- 2236(02)02263-4.
37. Brown DR, Nicholas RS, Canevari L. Lack of prion protein expression results in a neuronal phenotype sensitive to stress. J Neurosci Res 2002; 67:211- 24; PMID:11782965; http://dx.doi.org/10.1002/ jnr.10118.
38. Criado JR, Sánchez-Alavez M, Conti B, Giacchino JL, Wills DN, Henriksen SJ, et al. Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons. Neurobiol Dis 2005; 19:255-65; PMID:15837581; http://dx.doi. org/10.1016/j.nbd.2005.01.001.
39. Gadotti VM, Bonfield SP, Zamponi GW. Depressive-like behaviour of mice lacking cellular prion protein. Behav Brain Res 2011; PMID:21439331.
40. Xikota JC, Rial D, Ruthes D, Pereira R, Figueiredo CP, Prediger RD, et al. Mild cognitive deficits associated to neocortical microgyria in mice with genetic deletion of cellular prion protein. Brain Res 2008; 1241:148-56; PMID:18840415; http://dx.doi. org/10.1016/j.brainres.2008.08.097.
41. Walz R, Amaral OB, Rockenbach IC, Roesler R, Izquierdo I, Cavalheiro EA, et al. Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia 1999; 40:1679-82; PMID:10612329; http://dx.doi.org/10.1111/j.1528- 157.1999.tb01583.x.
42. Rangel A, Burgaya F, Gavín R, Soriano E, Aguzzi A, Del Río JA. Enhanced susceptibility of Prnp-deficient mice to kainate-induced seizures, neuronal apoptosis and death: Role of AMPA/kainate receptors. J Neurosci Res 2007; 85:2741-55; PMID:17304577; http://dx.doi.org/10.1002/jnr.21215.
43. Walz R, Castro RM, Velasco TR, Carlotti CG Jr, Sakamoto AC, Brentani RR, et al. Cellular prion protein: implications in seizures and epilepsy. Cell Mol Neurobiol 2002; 22:249-57; PMID:12469868; http://dx.doi.org/10.1023/A: 1020711700048.
44. Cagainst kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6/7-PSD-95 binding. Mol Biol Cell 2011; 22:3041-54; PMID:21757544; http://dx.doi. org/10.1091/mbc.E11-04-0321.
45. Khosravani H, Zhang Y, Tsutsui S, Hameed S, Altier C, Hamid J, et al. Prion protein attenuates excito-toxicity by inhibiting NMDA receptors. J Cell Biol 2008; 181:551-65; PMID:18443219; http://dx.doi. org/10.1083/jcb.200711002.
46. Ratté S, Vreugdenhil M, Boult JK, Patel A, Asante EA, Collinge J, et al. Threshold for epileptiform activity is elevated in prion knockout mice. Neuroscience 2011; 179:56-61; PMID:21277354; http://dx.doi. org/10.1016/j. neuroscience.2011.01.053.
47. Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev 2008; 88:673-728; PMID:18391177; http://dx.doi.org/10.1152/physrev. 00007.2007.
48. Au WJ, Gabor AJ, Vijayan N, Markand ON. Periodic lateralized epileptiform complexes (PLEDs) in Creutzfeldt-Jakob disease. Neurology 1980; 30:611- 7; PMID:6991974.
49. Neufeld MY, Talianski-Aronov A, Soffer D, Korczyn AD. Generalized convulsive status epilepticus in Creutzfeldt-Jakob disease. Seizure 2003; 12:403-5; PMID:12915087; http://dx.doi.org/10.1016/S1059- 1311(02)00378-3.
50. Lee K, Haight E, Olejniczak P. Epilepsia partialis continua in Creutzfeldt-Jakob disease. Acta Neurol Scand 2000; 102:398-402; PMID:11125757; http:// dx.doi.org/10.1034/j.1600-0404.2000.102006398.x.
51. Espinosa PS, Bensalem-Owen MK, Fee DB. Sporadic Creutzfeldt-Jakob disease presenting as nonconvulsive status epilepticus case report and review of the literature. Clin Neurol Neurosurg 2010; 112:537- 40; PMID:20430517; http://dx.doi.org/10.1016/j. clineuro.2010.03.025.
52. Maglio LE, Martins VR, Izquierdo I, Ramirez OA. Role of cellular prion protein on LTP expression in aged mice. Brain Res 2006; 1097:11-8; PMID:16730679; http://dx.doi.org/10.1016/j. brainres.2006.04.056.
53. Curtis J, Errington M, Bliss T, Voss K, MacLeod N. Age-dependent loss of PTP and LTP in the hippocampus of PrP-null mice. Neurobiol Dis 2003; 13:55-62; PMID:12758067; http://dx.doi. org/10.1016/S0969-9961(03)00017-2.
54. Rangel EB, Gonzalez AM, Linhares MM, Aguiar WF, Nogueira M, Ximenes S, et al. Asynchronous kidney allograft loss after simultaneous pancreas-kidney transplantation: impact on pancreas allograft outcome at a single center. Transplant Proc 2009; 41:1773-7; PMID:19545725; http://dx.doi. org/10.1016/j.transproceed.2009.01.107.
55. Lledo PM, Tremblay P, DeArmond SJ, Prusiner SB, Nicoll RA. Mice deficient for prion protein exhibit normal neuronal excitability and synaptic transmission in the hippocampus. Proc Natl Acad Sci USA 1996; 93:2403-7; PMID:8637886; http://dx.doi. org/10.1073/pnas.93.6.2403.
56. Carleton A, Tremblay P, Vincent JD, Lledo PM. Dose-dependent, prion protein (PrP)-mediated facilitation of excitatory synaptic transmission in the mouse hippocampus. Pflugers Arch 2001; 442:223- 9; PMID:11417218; http://dx.doi.org/10.1007/ s004240100523.
57. Walter ED, Stevens DJ, Spevacek AR, Visconte MP, Dei Rossi A, Millhauser GL. Copper binding extrinsic to the octarepeat region in the prion protein. Curr Protein Pept Sci 2009; 10:529-35; PMID:19538144; http://dx.doi.org/10.2174/ 138920309789352056.
58. Vassallo N, Herms J. Cellular prion protein function in copper homeostasis and redox signalling at the synapse. J Neurochem 2003; 86:538-44; PMID:12859667; http://dx.doi.org/10.1046/j.1471- 4159.2003.01882.x.
59. Farina F, Botto L, Chinello C, Cunati D, Magni F, Masserini M, et al. Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture. J Neurochem 2009; 110:1038-48; PMID:19493159; http://dx.doi.org/10.1111/j.1471- 4159.2009.06198.x.
60. Santuccione A, Sytnyk V, Leshchyns'ka I, Schachner M. Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J Cell Biol 2005; 169:341-54; PMID:15851519; http://dx.doi. org/10.1083/jcb.200409127.
61. Beraldo FH, Arantes CP, Santos TG, Machado CF, Roffe M, Hajj GN, et al. Metabotropic glutamate receptors transduce signals for neurite outgrowth after binding of the prion protein to laminin γ1 chain. FASEB J 2011; 25:265-79; PMID:20876210; http://dx.doi.org/10.1096/fj.10-161653.
62. Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloidbeta oligomers. Nature 2009; 457:1128-32; PMID:19242475; http://dx.doi.org/10.1038/ nature07761.
63. Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Laurén J, Gimbel ZA, et al. Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci 2010; 30:6367-74; PMID:20445063; http://dx.doi.org/10.1523/ JNEUROSCI.0395-10.2010.
64. Caetano FA, Beraldo FH, Hajj GN, Guimaraes AL, Jürgensen S, Wasilewska-Sampaio AP, et al. Amyloidbeta oligomers increase the localization of prion protein at the cell surface. J Neurochem 2011; 117:538-53; PMID:21352228; http://dx.doi. org/10.1111/j.1471-4159.2011.07225.x.
65. Saijo E, Scheff SW, Telling GC. Unaltered prion protein expression in Alzheimer disease patients. Prion 2011; 5:109-16; PMID:21654203; http://dx.doi. org/10.4161/pri.5.2.16355.
66. Takahashi RH, Tobiume M, Sato Y, Sata T, Gouras GK, Takahashi H. Accumulation of cellular prion protein within dystrophic neurites of amyloid plaques in the Alzheimer's disease brain. Neuropathology 2011; 31:208-14; PMID:21062360; http://dx.doi. org/10.1111/j.1440-789.2010.01158.x.
67. Zou WQ, Xiao X, Yuan J, Puoti G, Fujioka H, Wang X, et al. Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain. J Biol Chem 2011; 286:15095-105; PMID:21393248; http://dx.doi.org/10.1074/jbc.M110. 199356.
68. Re L, Rossini F, Re F, Bordicchia M, Mercanti A, Fernandez OS, et al. Prion protein potentiates acetylcholine release at the neuromuscular junction. Pharmacol Res 2006; 53:62-8; PMID:16256362; http://dx.doi.org/10.1016/j.phrs. 2005.09.002.
69. Hetz C, Maundrell K, Soto C. Is loss of function of the prion protein the cause of prion disorders? Trends Mol Med 2003; 9:237-43; PMID:12829011; http:// dx.doi.org/10.1016/S1471-4914(03)00069-8.
70. Asuni AA, Cunningham C, Vigneswaran P, Perry VH, O'Connor V. Unaltered SNARE complex formation in an in vivo model of prion disease. Brain Res 2008; 1233:1-7; PMID:18706894; http://dx.doi. org/10.1016/j.brainres.2008.07.083.
71. Sisó S, Puig B, Varea R, Vidal E, Acín C, Prinz M, et al. Abnormal synaptic protein expression and cell death in murine scrapie. Acta Neuropathol 2002; 103:615-26; PMID:12012094; http://dx.doi. org/10.1007/s00401- 001-0512-6.
72. Benvegnù S, Roncaglia P, Agostini F, Casalone C, Corona C, Gustincich S, et al. Developmental influence of the cellular prion protein on the gene expression profile in mouse hippocampus. Physiol Genomics 2011; 43:711-25; PMID:21406608; http://dx.doi. org/10.1152/physiolgenomics.00205.2010.
73. Skinner PJ, Abbassi H, Chesebro B, Race RE, Reilly C, Haase AT. Gene expression alterations in brains of mice infected with three strains of scrapie. BMC Genomics 2006; 7:114; PMID:16700923; http:// dx.doi.org/10.1186/1471-2164- 7-114.
74. Tang Y, Xiang W, Terry L, Kretzschmar HA, Windl O. Transcriptional analysis implicates endoplasmic reticulum stress in bovine spongiform encephalopathy. PLoS One 2010; 5:14207; PMID:21151970; http://dx.doi.org/10. 1371/journal.pone.0014207.
75. Sorensen G, Medina S, Parchaliuk D, Phillipson C, Robertson C, Booth SA. Comprehensive transcriptional profiling of prion infection in mouse models reveals networks of responsive genes. BMC Genomics 2008; 9:114; PMID:18315872; http:// dx.doi.org/10.1186/1471-2164-9-114.
76. Kim HO, Snyder GP, Blazey TM, Race RE, Chesebro B, Skinner PJ. Prion disease induced alterations in gene expression in spleen and brain prior to clinical symptoms. Adv Appl Bioinform Chem 2008; 1:29- 50; PMID:21918605.
77. Lee KS, Linden R, Prado MA, Brentani RR, Martins VR. Towards cellular receptors for prions. Rev Med Virol 2003; 13:399-408; PMID:14625887; http:// dx.doi.org/10.1002/rmv.408.
78. Zafar S, von Ahsen N, Oellerich M, Zerr I, Schulz- Schaeffer WJ, Armstrong VW, et al. Proteomics approach to identify the interacting partners of cellular prion protein and characterization of Rab7a interaction in neuronal cells. J Proteome Res 2011; 10:3123-35; PMID:21604690; http://dx.doi. org/10.1021/pr2001989.
79. Taylor DR, Hooper NM. The prion protein and lipid rafts. Mol Membr Biol 2006; 23:89-99; PMID:16611584; http://dx.doi. org/10.1080/09687860500449994.
80. Chen S, Mangé A, Dong L, Lehmann S, Schachner M. Prion protein as trans-interacting partner for neurons is involved in neurite outgrowth and neuronal survival. Mol Cell Neurosci 2003; 22:227-33; PMID:12676532; http://dx.doi.org/10.1016/S1044- 7431(02)00014-3.
81. Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, et al. Signal transduction through prion protein. Science 2000; 289:1925-8; PMID:10988071; http://dx.doi. org/10.1126/science.289.5486.1925.
82. Mouillet-Richard S, Schneider B, Pradines E, Pietri M, Ermonval M, Grassi J, et al. Cellular prion protein signaling in serotonergic neuronal cells. Ann NY Acad Sci 2007; 1096:106-19; PMID:17405922; http://dx.doi.org/10.1196/annals. 1397.076.
83. Pradines E, Loubet D, Schneider B, Launay JM, Kellermann O, Mouillet-Richard S. CREB-dependent gene regulation by prion protein: impact on MMP-9 and beta-dystroglycan. Cell Signal 2008; 20:2050-8; PMID:18718863; http://dx.doi. org/10.1016/j.cellsig.2008.07.016.
84. Schneider B, Mutel V, Pietri M, Ermonval M, Mouillet-Richard S, Kellermann O. NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells. Proc Natl Acad Sci USA 2003; 100:13326- 31; PMID:14597699; http://dx.doi.org/10.1073/ pnas.2235648100.
85. Solforosi L, Criado JR, McGavern DB, Wirz S, Sánchez-Alavez M, Sugama S, et al. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 2004; 303:1514-6; PMID:14752167; http://dx.doi.org/ 10.1126/science.1094273.
86. Chiarini LB, Freitas AR, Zanata SM, Brentani RR, Martins VR, Linden R. Cellular prion protein transduces neuroprotective signals. EMBO J 2002; 21:3317-26; PMID:12093733; http://dx.doi. org/10.1093/emboj/cdf324.
87. Martins VR, Beraldo FH, Hajj GN, Lopes MH, Lee KS, Prado MM, et al. Prion protein: orchestrating neurotrophic activities. Curr Issues Mol Biol 2010; 12:63-86; PMID:19767651.
88. Steele AD, Zhou Z, Jackson WS, Zhu C, Auluck P, Moskowitz MA, et al. Context dependent neuro-protective properties of prion protein (PrP). Prion 2009; 3:240-9; PMID:19901559; http://dx.doi. org/10.4161/pri.3.4.10135.
89. McLennan NF, Brennan PM, McNeill A, Davies I, Fotheringham A, Rennison KA, et al. Prion protein accumulation and neuroprotection in hypoxic brain damage. Am J Pathol 2004; 165:227-35; PMID:15215178; http://dx.doi.org/10.1016/ S0002- 9440(10)63291-9.
90. Mehan S, Meena H, Sharma D, Sankhla R. JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities. J Mol Neurosci 2011; 43:376-90; PMID:20878262; http://dx.doi. org/10.1007/s12031-010-9454-6.
91. Peng J, Andersen JK. The role of c-Jun N-terminal kinase (JNK) in Parkinson's disease. IUBMB Life 2003; 55:267-71; PMID:12880208; http://dx.doi. org/10.1080/1521654031000121666.
92. Yang DD, Kuan CY, Whitmarsh AJ, Rincón M, Zheng TS, Davis RJ, et al. Absence of excitotoxicity- induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 1997; 389:865-70; PMID:9349820; http://dx.doi.org/10.1038/39899.
93. Kuan CY, Burke RE. Targeting the JNK signaling pathway for stroke and Parkinson's diseases therapy. Curr Drug Targets CNS Neurol Disord 2005; 4:63-7; PMID:15723614; http://dx.doi. org/10.2174/1568007053005145.
94. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Dérijard B, et al. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 1996; 15:2760-70; PMID:8654373.
95. Quigley HA, Cone FE, Gelman SE, Yang Z, Son JL, Oglesby EN, et al. Lack of neuroprotection against experimental glaucoma in c-Jun N-terminal kinase 3 knockout mice. Exp Eye Res 2011; 92:299- 305; PMID:21272576; http://dx.doi.org/10.1016/j. exer.2011.01.006.
96. Brecht S, Kirchhof R, Chromik A, Willesen M, Nicolaus T, Raivich G, et al. Specific pathophysiological functions of JNK isoforms in the brain. Eur J Neurosci 2005; 21:363-77; PMID:15673436; http:// dx.doi.org/10.1111/j.1460-9568. 2005.03857.x.
97. Han D, Zhang QG, Yong-Liu, Li C, Zong YY, Yu CZ, et al. Co-activation of GABA receptors inhibits the JNK3 apoptotic pathway via the disassembly of the GluR6-PSD95-MLK3 signaling module in cerebral ischemic-reperfusion. FEBS Lett 2008; 582:1298-306; PMID:18307989; http://dx.doi. org/10.1016/j.febslet.2008.02. 044.
98. Li C, Xu B, Wang WW, Yu XJ, Zhu J, Yu HM, et al. Coactivation of GABA receptors inhibits the JNK3 apoptotic pathway via disassembly of GluR6-PSD- 95-MLK3 signaling module in KA-induced seizure. Epilepsia 2010; 51:391-403; PMID:19694794; http://dx.doi.org/10.1111/j.1528-167.2009.02270.x.
99. Tian H, Zhang QG, Zhu GX, Pei DS, Guan QH, Zhang GY. Activation of c-Jun NH2-terminal kinase 3 is mediated by the GluR6.PSD-95.MLK3 signaling module following cerebral ischemia in rat hippocampus. Brain Res 2005; 1061:57-66; PMID:16256962; http://dx.doi.org/10.1016/j.brainres.2005.09.001.
100. Mulle C, Sailer A, Pérez-Otaño I, Dickinson-Anson H, Castillo PE, Bureau I, et al. Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice. Nature 1998; 392:601-5; PMID:9580260; http://dx.doi. org/10.1038/33408.
101. Behrens A, Sibilia M, Wagner EF. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet 1999; 21:326-9; PMID:10080190; http://dx.doi. org/10.1038/6854.
102. Watts JC, Huo H, Bai Y, Ehsani S, Jeon AH, Shi T, et al. Interactome analyses identify ties of PrP and its mammalian paralogs to oligomannosidic N-glycans and endoplasmic reticulum-derived chaperones. PLoS Pathog 2009; 5:1000608; PMID:19798432; http://dx.doi.org/10.1371/journal.ppat.1000608.
103. Rutishauser D, Mertz KD, Moos R, Brunner E, Rülicke T, Calella AM, et al. The comprehensive native interactome of a fully functional tagged prion protein. PLoS One 2009; 4:4446; PMID:19209230; http://dx.doi.org/10.1371/ journal.pone.0004446.
104. Spielhaupter C, Schätzl HM. PrPC directly interacts with proteins involved in signaling pathways. J Biol Chem 2001; 276:44604-12; PMID:11571277; http://dx.doi.org/10.1074/jbc.M103289200.
105. Zanata SM, Lopes MH, Mercadante AF, Hajj GN, Chiarini LB, Nomizo R, et al. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J 2002; 21:3307- 16; PMID:12093732; http://dx.doi.org/10.1093/ emboj/cdf325.
106. Beraldo FH, Arantes CP, Santos TG, Queiroz NG, Young K, Rylett RJ, et al. Role of alpha7 nicotinic acetylcholine receptor in calcium signaling induced by prion protein interaction with stress-inducible protein 1. J Biol Chem 2010; 285:36542- 50; PMID:20837487; http://dx.doi.org/10.1074/jbc. M110.157263.
107. Roffé M, Beraldo FH, Bester R, Nunziante M, Bach C, Mancini G, et al. Prion protein interaction with stress-inducible protein 1 enhances neuronal protein synthesis via mTOR. Proc Natl Acad Sci USA 2010; 107:13147-52; PMID:20615969; http:// dx.doi.org/10.1073/pnas.1000784107.
108. Steele AD. All quiet on the neuronal front: NMDA receptor inhibition by prion protein. J Cell Biol 2008; 181:407-9; PMID:18443224; http://dx.doi. org/10.1083/jcb.200803152.
109. Baumann F, Pahnke J, Radovanovic I, Rülicke T, Bremer J, Tolnay M, et al. Functionally relevant domains of the prion protein identified in vivo. PLoS One 2009; 4:6707; PMID:19738901; http://dx.doi. org/10.1371/journal.pone. 0006707.
110. Chesebro B, Race B, Meade-White K, Lacasse R, Race R, Klingeborn M, et al. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring. PLoS Pathog 2010; 6:1000800; PMID:20221436; http://dx.doi.org/10.1371/journal.ppat.1000800.